Target Information
Target General Information | Top | |||||
---|---|---|---|---|---|---|
Target ID |
T46658
(Former ID: TTDI01259)
|
|||||
Target Name |
Eosinophil/lymphocyte-rich accumulation (ELR accum)
|
|||||
Gene Name |
NO-GeName
|
|||||
Target Type |
Clinical trial target
|
[1] | ||||
Disease | [+] 1 Target-related Diseases | + | ||||
1 | Asthma [ICD-11: CA23] | |||||
UniProt ID |
Drugs and Modes of Action | Top | |||||
---|---|---|---|---|---|---|
Clinical Trial Drug(s) | [+] 1 Clinical Trial Drugs | + | ||||
1 | PNU-142731A | Drug Info | Phase 2 | Asthma | [2] | |
Mode of Action | [+] 1 Modes of Action | + | ||||
Modulator | [+] 1 Modulator drugs | + | ||||
1 | PNU-142731A | Drug Info | [1] |
References | Top | |||||
---|---|---|---|---|---|---|
REF 1 | Preclinical evaluation of anti-inflammatory activities of the novel pyrrolopyrimidine PNU-142731A, a potential treatment for asthma. J Pharmacol Exp Ther. 1999 Jul;290(1):188-95. | |||||
REF 2 | Clinical pipeline report, company report or official report of pubfacts. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.